Development and external validation of a prognostic model for survival of people living with HIV/AIDS initiating antiretroviral therapy
Junfeng Wang(Utrecht University), Huachun Zou(Fudan University), Quanmin Li(Chinese PLA General Hospital), Hong Shang(Chinese Academy of Medical Sciences & Peking Union Medical College), Weiping Cai(Guangzhou Eighth People's Hospital), Leiwen Fu(Beijing Chest Hospital), Haibo Ding(First Hospital of China Medical University), Qiyu Zhu, Junjie Xu(Kunming University of Science and Technology), Xiaoping Tang(Guangzhou Eighth People's Hospital), Xuemei Ling(Wenzhou Medical University), Linghua Li(Guangzhou Eighth People's Hospital), Willem R. Keusters(Utrecht University), Tanwei Yuan(German Cancer Research Center)
Cited by 22
Related Papers
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
|Journal of Infection|2020|1.2k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|654
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
|Cancer Cell|2023|246
Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection
|Immunity|2017|184
Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study
|JMIR Public Health and Surveillance|2023|167